According to statistics, about 65% of lung cancer patients have high expression of serum CEA, and patients with lung adenocarcinoma have higher serum CEA levels than patients with lung squamous cell carcinoma and small cell lung cancer. Here, CEACAM5 is linked to lung adenocarcinoma.